ZA98831B - (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents - Google Patents

(4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents

Info

Publication number
ZA98831B
ZA98831B ZA98831A ZA98831A ZA98831B ZA 98831 B ZA98831 B ZA 98831B ZA 98831 A ZA98831 A ZA 98831A ZA 98831 A ZA98831 A ZA 98831A ZA 98831 B ZA98831 B ZA 98831B
Authority
ZA
South Africa
Prior art keywords
piperidinyl
derivatives useful
antipsychotic agents
benzopyran derivatives
benzopyran
Prior art date
Application number
ZA98831A
Other languages
English (en)
Inventor
Joseph T Stupczewski
Kenneth J Bordeau
Shelley L Pavlek
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of ZA98831B publication Critical patent/ZA98831B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA98831A 1997-02-07 1998-02-02 (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents ZA98831B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79710797A 1997-02-07 1997-02-07

Publications (1)

Publication Number Publication Date
ZA98831B true ZA98831B (en) 1998-08-07

Family

ID=25169927

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA98831A ZA98831B (en) 1997-02-07 1998-02-02 (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents

Country Status (22)

Country Link
EP (1) EP1015446B1 (no)
JP (1) JP4177461B2 (no)
KR (1) KR100509878B1 (no)
CN (1) CN1092653C (no)
AR (1) AR011614A1 (no)
AT (1) ATE236150T1 (no)
AU (1) AU725301B2 (no)
BR (1) BRPI9807312B8 (no)
CA (1) CA2281702C (no)
CY (1) CY2324B1 (no)
DE (1) DE69812980T2 (no)
DK (1) DK1015446T3 (no)
ES (1) ES2194303T3 (no)
HK (1) HK1027812A1 (no)
HU (1) HUP0001308A3 (no)
IL (1) IL131243A (no)
NO (1) NO318936B1 (no)
NZ (1) NZ336719A (no)
PT (1) PT1015446E (no)
TW (1) TW518333B (no)
WO (1) WO1998034933A1 (no)
ZA (1) ZA98831B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1749001T3 (da) * 2004-04-29 2010-06-28 Aventis Pharma Inc 3-piperidinylisochroman-5-ol som dopaminagonister
PL1748767T3 (pl) 2004-05-28 2012-08-31 Unigen Inc 1-(3-metylo-2,4-dimetoksyfenylo)-3-(2',4'-dihydroksyfenylo)-propan jako silny inhibitor tyrozynazy
EP2183245B1 (en) 2007-07-26 2014-07-09 F. Hoffmann-La Roche AG Dual modulators of 5-ht2a and d3 receptors
JP2011528719A (ja) 2008-07-21 2011-11-24 ユニジェン・インコーポレーテッド スキンホワイトニング(色を薄くする)化合物系列
US8877778B2 (en) 2010-12-15 2014-11-04 Hoffmann-La Roche Inc. Benzofurane compounds
CN102079720B (zh) * 2011-01-20 2013-02-06 蚌埠丰原医药科技发展有限公司 一种制备1-苄基-4-哌啶甲醛的方法
CN109180448A (zh) 2011-03-24 2019-01-11 尤尼根公司 用于制备二芳基丙烷的化合物和方法
US8921397B2 (en) 2011-05-04 2014-12-30 Hoffmann-La Roche Inc. Benzofurane-piperidine compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552004A (en) * 1976-05-26 1979-09-05 Takeda Chemical Industries Ltd Isochroman derivatives
US4963568A (en) * 1989-05-31 1990-10-16 Abbott Laboratories Dopamine agonists

Also Published As

Publication number Publication date
BRPI9807312B8 (pt) 2016-09-13
PT1015446E (pt) 2003-08-29
HUP0001308A3 (en) 2001-07-30
WO1998034933A1 (en) 1998-08-13
CN1246859A (zh) 2000-03-08
JP4177461B2 (ja) 2008-11-05
CY2324B1 (en) 2003-11-14
EP1015446B1 (en) 2003-04-02
DE69812980T2 (de) 2003-11-13
AR011614A1 (es) 2000-08-30
AU725301B2 (en) 2000-10-12
ATE236150T1 (de) 2003-04-15
KR100509878B1 (ko) 2005-08-25
TW518333B (en) 2003-01-21
CN1092653C (zh) 2002-10-16
KR20000070862A (ko) 2000-11-25
EP1015446A1 (en) 2000-07-05
HUP0001308A2 (hu) 2001-06-28
NO318936B1 (no) 2005-05-30
BR9807312A (pt) 2000-05-02
CA2281702A1 (en) 1998-08-13
JP2001512436A (ja) 2001-08-21
BR9807312B1 (pt) 2013-10-29
DE69812980D1 (de) 2003-05-08
IL131243A (en) 2004-02-19
ES2194303T3 (es) 2003-11-16
NO993812D0 (no) 1999-08-06
DK1015446T3 (da) 2003-07-14
AU5923798A (en) 1998-08-26
NO993812L (no) 1999-10-05
NZ336719A (en) 2000-10-27
HK1027812A1 (en) 2001-01-23
IL131243A0 (en) 2001-01-28
CA2281702C (en) 2006-04-11

Similar Documents

Publication Publication Date Title
EG24433A (en) Novel benzolimidazole derivatives useful as antiproliferative agents
EG23756A (en) D-proline derivatives
IL148105A0 (en) Triazinylaminostilbene derivative as fluorescent whitening agents
HK1025322A1 (en) Novel spiroazabicyclic heterocyclic compounds
PL334847A1 (en) Substituted 3-heterocyclyl-benzoyl derivatives
IL132170A0 (en) Novel heterocyclic compounds
GB9715892D0 (en) Heterocyclic compounds
ZA9811345B (en) Piperidine derivatives
ZA981920B (en) Novel heterocyclic compounds
ZA98831B (en) (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents
IL123860A0 (en) Phenoxymethyl piperidine derivatives
SI1015446T1 (en) (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents
HUP0002727A3 (en) Methods for reducing fibrinogen using benzotiophene derivatives
ZA985448B (en) Novel heterocyclic compounds
PL336639A1 (en) Novel heterocyclic compounds
IL135195A0 (en) Substituted piperidine derivatives
EP1011665A4 (en) HETEROCYCLIC AGENTS
ZA982618B (en) Phenoxymethyl piperidines derivatives
ZA989889B (en) D-proline derivatives
GB9715893D0 (en) Heterocyclic derivatives
GB9715970D0 (en) Heterocyclic derivatives
ZA985449B (en) Novel heterocyclic compounds
PL322697A1 (en) Novel compound - furane derivatives
GB9719237D0 (en) Heterocyclic compounds
GB9716378D0 (en) Heterocyclic compounds